Search results for

Researchers say the experimental Alzheimer's drug Lecanemab represents an important advance and is likely to get FDA approval in 2023, despite some safety concerns.

At his ramen shop in Cambridge, Mass., chef Tsuyoshi Nishioka wants customers to follow their dreams. His philosophy? If you can finish a bowl of his ramen, you can accomplish anything in life.

The IMAGINE PEACE exhibit by famed artist and activist Yoko Ono opens Jan. 24 at the Bob Rauschenberg Gallery at Edison State College in Fort Myers. The…

This spring, orchards in Washington state are being ripped up to make room for a new apple variety called Cosmic Crisp. This is what happens before it hits store shelves.

The health law again faces possible legal evisceration with a court ruling in Texas v. Azar anticipated this fall. Here's what it's about and what's stake.

NPR's Audie Cornish talks to Angela Allen-Bell, a professor at the Southern University Law Center. She got to know and became an advocate for Albert Woodfox during her work on solitary confinement.

The Tallahassee Chamber of Commerce continues examining whether consolidating city and county services would be a good fit for the area. But it’s...

Under the plan, single people earning incomes below $75,000 will receive as much as $1,200. The White House says it will issue funds in three weeks but experts say it could take months for some.

Tom Barrack is one of President Trump's oldest friends. He's also been the subject of unwelcome headlines recently, over comments concerning Saudi Arabia and his role in Trump's inauguration.

The long-awaited GOP health care plan is out. President Trump and Republicans might have an easier time passing it than Obama eight years ago, but health care is complicated and not an easy sell.